Breast Cancer Xenografts in Nude Rats Exposed to Light at Night Stimulates Growth of Human Melatonin-Depleted Blood from Premenopausal Women

The increased breast cancer risk in female night shift workers has been postulated to result from the suppression of pineal melatonin production by exposure to light at night. Exposure of rats bearing rat hepatomas or human breast cancer xenografts to increasing intensities of white fluorescent light during each 12-hour dark phase (0-345 MW/cm) resulted in a dose-dependent suppression of nocturnal melatonin blood levels and a stimulation of tumor growth and linoleic acid uptake/metabolism to the mitogenic molecule 13-hydroxyoctadecadienoic acid. Venous blood samples were collected from healthy, premenopausal female volunteers during either the daytime, nighttime, or nighttime following 90 minutes of ocular bright, white fluorescent light exposure at 580 MW/cm (i.e., 2,800 lx). Compared with tumors perfused with daytimecollected melatonin-deficient blood, human breast cancer xenografts and rat hepatomas perfused in situ , with nocturnal, physiologically melatonin-rich blood collected during the night, exhibited markedly suppressed proliferative activity and linoleic acid uptake/metabolism. Tumors perfused with melatonin-deficient blood collected following ocular exposure to light at night exhibited the daytime pattern of high tumor proliferative activity. These results are the first to show that the tumor growth response to exposure to light during darkness is intensity dependent and that the human nocturnal, circadian melatonin signal not only inhibits human breast cancer growth but that this effect is extinguished by short-term ocular exposure to bright, white light at night. These mechanistic studies are the first to provide a rational biological explanation for the increased breast cancer risk in female night shift workers. (Cancer Res 2005; 65(23): 11174-84)

[1]  D. Blask,et al.  Oral melatonin supplementation in rats and a human subject suppresses the growth activity of steroid receptor negative human breast cancer xenografts in female nude rats via an MT1 receptor-mediated suppression of signal tranduction and linoleic acid uptake and metabolism , 2005 .

[2]  K. Welham,et al.  Conjugated linoleic acid isomers and trans fatty acids inhibit fatty acid transport in hepatoma 7288CTC and inguinal fat pads in Buffalo rats. , 2004, The Journal of nutrition.

[3]  D. Blask,et al.  Melatonin uptake and growth prevention in rat hepatoma 7288CTC in response to dietary melatonin: melatonin receptor-mediated inhibition of tumor linoleic acid metabolism to the growth signaling molecule 13-hydroxyoctadecadienoic acid and the potential role of phytomelatonin. , 2004, Carcinogenesis.

[4]  Vincent Laudet,et al.  The days and nights of cancer cells. , 2003, Cancer research.

[5]  M. Dubocovich,et al.  Molecular pharmacology, regulation and function of mammalian melatonin receptors. , 2003, Frontiers in bioscience : a journal and virtual library.

[6]  Francine Laden,et al.  Night-shift work and risk of colorectal cancer in the nurses' health study. , 2003, Journal of the National Cancer Institute.

[7]  David E. Blask,et al.  Growth and Fatty Acid Metabolism of Human Breast Cancer (MCF-7) Xenografts in Nude Rats: Impact of Constant Light-Induced Nocturnal Melatonin Suppression , 2003, Breast Cancer Research and Treatment.

[8]  J. Boutin,et al.  New selective ligands of human cloned melatonin MT1 and MT2 receptors , 2003, Naunyn-Schmiedeberg's Archives of Pharmacology.

[9]  L. Fu,et al.  The circadian clock: pacemaker and tumour suppressor , 2003, Nature Reviews Cancer.

[10]  S. Hampton,et al.  Circadian Aspects of Postprandial Metabolism , 2003, Chronobiology international.

[11]  T. Eling,et al.  Opposing Effects of 15-Lipoxygenase-1 and -2 Metabolites on MAPK Signaling in Prostate , 2002, The Journal of Biological Chemistry.

[12]  R. Cheney,et al.  Differential expression of high-affinity melatonin receptors (MT1) in normal and malignant human breast tissue. , 2002, American journal of clinical pathology.

[13]  T. Åkerstedt,et al.  Metabolic responses to nocturnal eating in men are affected by sources of dietary energy. , 2002, The Journal of nutrition.

[14]  Prahlad T. Ram,et al.  Involvement of the mt1 melatonin receptor in human breast cancer. , 2002, Cancer letters.

[15]  D. Blask,et al.  Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy. , 2002, Current topics in medicinal chemistry.

[16]  R. Stevens,et al.  Night shift work, light at night, and risk of breast cancer. , 2001, Journal of the National Cancer Institute.

[17]  F Laden,et al.  Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. , 2001, Journal of the National Cancer Institute.

[18]  Josephine Arendt,et al.  Health in a 24-h society , 2001, The Lancet.

[19]  D. Blask,et al.  Printed in U.S.A. Copyright © 2001 by The Endocrine Society Inhibition of Isoproterenol-Induced Lipolysis in Rat Inguinal Adipocytes in Vitro by Physiological Melatonin via a Receptor-Mediated Mechanism , 2022 .

[20]  G. Brainard,et al.  Action Spectrum for Melatonin Regulation in Humans: Evidence for a Novel Circadian Photoreceptor , 2001, The Journal of Neuroscience.

[21]  Mark S. Rea,et al.  Light in the Built Environment: Potential role of Circadian Disruption in Endocrine Disruption and Breast Cancer , 2001, Cancer Causes & Control.

[22]  P. Goss,et al.  Estrogen and the risk of breast cancer. , 2001, The New England journal of medicine.

[23]  Johnni Hansen,et al.  Increased Breast Cancer Risk among Women Who Work Predominantly at Night , 2001, Epidemiology.

[24]  W. Hrushesky.  The temporal organization of life: the impact of multi-frequency non-linear biologic time structure upon the host-cancer balance. , 2000, Japanese journal of clinical oncology.

[25]  H. Kraemer,et al.  Diurnal cortisol rhythm as a predictor of breast cancer survival. , 2000, Journal of the National Cancer Institute.

[26]  G. Brainard,et al.  Dim light during darkness stimulates tumor progression by enhancing tumor fatty acid uptake and metabolism. , 1999, Cancer letters.

[27]  D. Blask,et al.  Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events. , 1999, Cancer research.

[28]  R. Stevens,et al.  Inverse association between breast cancer incidence and degree of visual impairment in Finland , 1999, British Journal of Cancer.

[29]  G. Brainard,et al.  Photic Regulation of Melatonin in Humans: Ocular and Neural Signal Transduction , 1997, Journal of biological rhythms.

[30]  A C Bird,et al.  Relationship between melatonin rhythms and visual loss in the blind. , 1997, The Journal of clinical endocrinology and metabolism.

[31]  W. Glasgow,et al.  The Linoleic Acid Metabolite, (13S)-Hydroperoxyoctadecadienoic Acid, Augments the Epidermal Growth Factor Receptor Signaling Pathway by Attenuation of Receptor Dephosphorylation , 1997, The Journal of Biological Chemistry.

[32]  J. Gusella,et al.  Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[33]  S. Reppert,et al.  Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses , 1994, Neuron.

[34]  W. Hrushesky.  Timing Is Everything , 1994 .

[35]  C. A. Bernecker,et al.  Biological Effects of Architectural Lighting and Their Associated Energy Utilization , 1994 .

[36]  R. Reiter,et al.  Pineal melatonin: cell biology of its synthesis and of its physiological interactions. , 1991, Endocrine reviews.

[37]  R. Reiter.  Pineal gland : interface between the photoperiodic environment and the endocrine system , 1991 .

[38]  N. Kerenyi,et al.  Why the incidence of cancer is increasing: the role of 'light pollution'. , 1990, Medical hypotheses.

[39]  S. Hill,et al.  Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. , 1988, Cancer research.

[40]  L. Sauer,et al.  Identification of linoleic and arachidonic acids as the factors in hyperlipemic blood that increase [3H]thymidine incorporation in hepatoma 7288CTC perfused in situ. , 1988, Cancer research.

[41]  R. Stevens,et al.  Electric power use and breast cancer: a hypothesis. , 1987, American journal of epidemiology.

[42]  G. Brainard,et al.  The suppression of pineal melatonin content and N-acetyltransferase activity by different light irradiances in the Syrian hamster: a dose-response relationship. , 1983, Endocrinology.

[43]  G. Brainard,et al.  The effect of different light intensities on pineal melatonin content , 1982, Brain Research.

[44]  M. Lippman,et al.  PINEAL GLAND AND BREAST CANCER , 1978, The Lancet.

[45]  H. Iwase,et al.  [Breast cancer]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.

[46]  R. Stevens,et al.  Structural Variation : A Circadian Biomarker Associated with Breast Cancer in Young Women , 2005 .

[47]  U. Kelavkar,et al.  15-lipoxygenase-1 expression upregulates and activates insulin-like growth factor-1 receptor in prostate cancer cells. , 2004, Neoplasia.

[48]  S. M. Pauley.  Lighting for the human circadian clock: recent research indicates that lighting has become a public health issue. , 2004, Medical hypotheses.

[49]  Jared Rutter,et al.  Metabolism and the control of circadian rhythms. , 2002, Annual review of biochemistry.

[50]  W. Hrushesky.  Tumor chronobiology. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[51]  M. Dubocovich,et al.  Activation of MT(2) melatonin receptors in rat suprachiasmatic nucleus phase advances the circadian clock. , 2001, American journal of physiology. Cell physiology.

[52]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[53]  S. Hill,et al.  Effects of melatonin on cancer: studies on MCF-7 human breast cancer cells in culture. , 1986, Journal of neural transmission. Supplementum.